Cardiovascular Disease and Lipoprotein(a)
3 clinical trials · Condition
◉ Watch Cardiovascular Disease and Lipoprotein(a)
| Record | Firm | Date |
|---|---|---|
| Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD (NCT04023552) | Novartis Pharmaceuticals | 2019-12-12 |
| Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) (NCT03887520) | Novartis Pharmaceuticals | 2018-11-27 |
Track Cardiovascular Disease and Lipoprotein(a) automatically
Every clearance here is in the API, with alerts when new ones post.